Prostatis Group’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-4,717
Closed -$201K – 136
2024
Q2
$201K Buy
+4,717
New +$198K 0.07% 143
2023
Q1
– Sell
-73,452
Closed -$2.78M – 100
2022
Q4
$2.78M Buy
+73,452
New +$2.71M 1.7% 15
2022
Q2
– Sell
-57,966
Closed -$2.62M – 56
2022
Q1
$2.62M Buy
+57,966
New +$2.74M 2.1% 19
2021
Q2
– Sell
-4,058
Closed -$216K – 105
2021
Q1
$216K Sell
4,058
-39,529
-91% -$2.16M 0.17% 89
2020
Q4
$2.25M Buy
+43,587
New +$2.1M 1.89% 12

Other funds holding EEM

Prostatis Group's EEM Position: Q3 2024 in Review

Prostatis Group sold out of iShares MSCI Emerging Markets ETF (EEM) in Q3 2024, closing a stake of 4,717 shares — an estimated $201K sold.

Prostatis Group first reported a position in EEM in Q4 2020 and held it in 5 quarters. The position peaked at $2.78M in Q4 2022. 1,287 funds tracked by Wall St. Rank hold EEM as of Q3 2024.

  • Prostatis Group reported no remaining iShares MSCI Emerging Markets ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 4,717 iShares MSCI Emerging Markets ETF shares in Q3 2024, an estimated $201K.
  • Prostatis Group first reported a position in iShares MSCI Emerging Markets ETF in Q4 2020 and held it in 5 quarters.
  • Prostatis Group's iShares MSCI Emerging Markets ETF position peaked at $2.78M in Q4 2022.
  • 1,287 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.